Iterum Therapeutics Plc

NASDAQ:ITRM   1:37:01 PM EDT
1.19
+0.02 (+1.92%)
Earnings Announcements

Iterum Therapeutics Reports Q3 2022 Results

Published: 11/10/2022 12:34 GMT
Iterum Therapeutics Plc (ITRM) - Iterum Therapeutics Reports Third Quarter 2022 Financial Results.
Qtrly Loss per Share $2.38.
Qtrly Adjusted Loss per Share $0.43.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.15

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.18

More details on our Analysts Page.